Pablo Andrés Moncada

Phase 2/3 Trial of Molnupiravir for Treatment of Covid-19 in Nonhospitalized Adults

Yoseph Caraco, Gordon Crofoot, Pablo Andrés Moncada et al. · NEJM Evidence · 2021 · 96 citations

Health Sciences, Covid-19 Pandemic, Antiviral Drug Development +14

Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19

Matthew G. Johnson, Amy Puenpatom, Pablo Andrés Moncada et al. · Annals of Internal Medicine · 2022 · 67 citations · Full text

Utility of DNA Sequencing for Direct Identification of Invasive Fungi From Fresh and Formalin-Fixed Specimens

Pablo Andrés Moncada, Indre Budvytiene, Dora Y. Ho et al. · American Journal of Clinical Pathology · 2013 · 51 citations · Full text

Hyperferritinemic syndrome: Still’s disease and catastrophic antiphospholipid syndrome triggered by fulminant Chikungunya infection: a case report of two patients

Juan‐Felipe Betancur, Erika‐Paola Navarro, Alex Echeverry et al. · Clinical Rheumatology · 2015 · 32 citations · Full text

Autoimmune Disease, Vasculitis, Pathogenesis +5

Emerging carbapenem-resistant Aeromonas spp. infections in Cali, Colombia

Fernando Rosso, Jorge Cedano, Luis Gabriel Parra‐Lara et al. · The Brazilian Journal of Infectious Diseases · 2019 · 32 citations · Full text